These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12858432)

  • 1. The endothelium and coagulopathy in systemic lupus erythematosus: hyperhomocysteinemia as a developing risk factor.
    Fijnheer R; Blann AD
    J Rheumatol; 2003 Jul; 30(7):1400-2. PubMed ID: 12858432
    [No Abstract]   [Full Text] [Related]  

  • 2. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia.
    Tam LS; Fan B; Li EK; Thomas GN; Yim SF; Haines CJ; Tomlinson B
    J Rheumatol; 2003 Jul; 30(7):1479-84. PubMed ID: 12858444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia and lower extremity wounds.
    Schwartzfarb EM; Romanelli P
    Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin.
    Olivier AC; Hollman JL
    J Invasive Cardiol; 2006 Jun; 18(6):E185-7. PubMed ID: 16775899
    [No Abstract]   [Full Text] [Related]  

  • 5. Portal and pulmonary hypertension in a case of systematic lupus erythematosus: possible relationship with a clotting abnormality.
    Mackworth-Young CG; Gharavi AE; Boey ML; Hughes GR
    Eur J Rheumatol Inflamm; 1984; 7(3):71-4. PubMed ID: 6443758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Shirokova IE; Lisitskaia TL
    Ter Arkh; 2006; 78(6):24-30. PubMed ID: 16881359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Homocysteine and rheumatic disease].
    Tinazzi I; Caramaschi P; Patuzzo G; Bambara LM; Biasi D
    Recenti Prog Med; 2007 Dec; 98(12):646-52. PubMed ID: 18369042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disseminated lupus erythematosus with circulating anticoagulant (proceedings)].
    Sandler B; Bentegeat J; Darmendrail J; Chatelan M; Authier F; Ainciburu PM; Bertin JB; Cheylac JY; Sautarel M
    Pediatrie; 1976 Sep; 31(6):624-5. PubMed ID: 1005003
    [No Abstract]   [Full Text] [Related]  

  • 9. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ
    Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The thrombocyte link in blood-coagulation homeostasis in patients with systemic lupus erythematosus].
    Vas'kova NG
    Vrach Delo; 1990 Nov; (11):51-3. PubMed ID: 2098984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus.
    Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Parks CG; Gilkeson GS
    Arthritis Rheum; 1998 Oct; 41(10):1714-24. PubMed ID: 9778212
    [No Abstract]   [Full Text] [Related]  

  • 12. Arterial thrombosis in systemic lupus erythematosus.
    Tanvetyanon T
    N Engl J Med; 2004 Oct; 351(18):1910-1; author reply 1910-1. PubMed ID: 15515221
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombophilia and thrombosis in systemic lupus erythematosus: a case-control study.
    Barcat D; Guérin V; Ryman A; Constans J; Vernhes JP; Vergnes C; Bonnet F; Delbrel X; Morlat P; Longy-Boursier M; Conri C
    Ann Rheum Dis; 2003 Oct; 62(10):1016-7. PubMed ID: 12972486
    [No Abstract]   [Full Text] [Related]  

  • 15. Homocysteine and the vascular endothelium.
    Jacobs P; Wood L
    S Afr Med J; 2003 Mar; 93(3):191-2. PubMed ID: 12768940
    [No Abstract]   [Full Text] [Related]  

  • 16. The pathophysiology of lupus erythematosus.
    Vanholder R; De Keyser F; Kips J; Praet M; Naeyaert JM
    Eur J Dermatol; 1998; 8(1):4-7. PubMed ID: 9649712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired factor XI inhibitor in systemic lupus erythematosus--case report and literature review.
    Bortoli R; Monticielo OA; Chakr RM; Palominos PE; Rohsig LM; Kohem CL; Xavier RM; Brenol JC
    Semin Arthritis Rheum; 2009 Aug; 39(1):61-5. PubMed ID: 18519152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The lupus anticoagulant].
    Ordi Ros J; Vilardell Tarrés M
    Med Clin (Barc); 1983 Jul; 81(4):178-81. PubMed ID: 6621149
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement deficiency states, disease susceptibility, and infection risk in systemic lupus erythematosus.
    Holers VM
    Arthritis Rheum; 1999 Oct; 42(10):2023-5. PubMed ID: 10524672
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus.
    Soep JB; Mietus-Snyder M; Malloy MJ; Witztum JL; von Scheven E
    Arthritis Rheum; 2004 Jun; 51(3):451-7. PubMed ID: 15188333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.